{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0007105,73,MONDO:0007105,109,0]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0007105","source":"MONDO:0007105|frontotemporal dementia and/or amyotrophic lateral sclerosis 1","targets":["NCT00043849|Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00127114|Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT00164970|Can Oral Vitamin B12 and Folate Supplementation Preserve Cognitive Function of Patients With Early Dementia?|COMPLETED|PHASE4|INTERVENTIONAL","NCT00177671|Antidepressant Medication Plus Donepezil for Treating Late-life Depression|COMPLETED|PHASE4|INTERVENTIONAL","NCT00208819|A Comparison of Two Standard Therapies in the Management of Dementia With Agitation|COMPLETED|PHASE4|INTERVENTIONAL","NCT00245206|Side Effects of Newer Antipsychotics in Older Adults|COMPLETED|PHASE4|INTERVENTIONAL","NCT00254033|Apathy Associated With Alzheimer's Disease|COMPLETED|PHASE4|INTERVENTIONAL","NCT00371059|Memantine for Agitation in Dementia|COMPLETED|PHASE4|INTERVENTIONAL","NCT00375557|Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT00385684|Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00433121|Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD|COMPLETED|PHASE4|INTERVENTIONAL","NCT00450047|Study on the Efficacy of Speed-Feedback Therapy for Elderly People With Dementia|COMPLETED|PHASE4|INTERVENTIONAL","NCT00495820|Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT00594269|Dementia Antipsychotics And Antidepressants Discontinuation Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT00626613|The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD)|UNKNOWN|PHASE4|INTERVENTIONAL","NCT00768261|Corticolimbic Degeneration and Treatment of Dementia|COMPLETED|PHASE4|INTERVENTIONAL","NCT00792662|Improving Function, Quality of Life, Glycemia in Diabetics With Dementia|WITHDRAWN|PHASE4|INTERVENTIONAL","NCT00814658|The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life|COMPLETED|PHASE4|INTERVENTIONAL","NCT00914095|Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease (PARKGAIT-II)|COMPLETED|PHASE4|INTERVENTIONAL","NCT01012830|Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01109836|Austrian Polyintervention Study to Prevent Cognitive Decline After Ischemic Stroke|COMPLETED|PHASE4|INTERVENTIONAL","NCT01340950|Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China|COMPLETED|PHASE4|INTERVENTIONAL","NCT01453127|DaTSCAN Imaging in Aging and Neurodegenerative Disease|ENROLLING_BY_INVITATION|PHASE4|INTERVENTIONAL","NCT01799941|Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA)|COMPLETED|PHASE4|INTERVENTIONAL","NCT01825577|Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia.|TERMINATED|PHASE4|INTERVENTIONAL","NCT01849042|Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease|UNKNOWN|PHASE4|INTERVENTIONAL","NCT02267057|Efficacy of Pain Treatment on Depression in Patients With Dementia|COMPLETED|PHASE4|INTERVENTIONAL","NCT02782429|The Role of Ketamine in Preventing Cognitive Dysfunctions in Postoperative Period of Cardiac Surgery|UNKNOWN|PHASE4|INTERVENTIONAL","NCT03061006|Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation|COMPLETED|PHASE4|INTERVENTIONAL","NCT03066518|Effect of Melatonin on Sleep Quality in Patients Dementia|COMPLETED|PHASE4|INTERVENTIONAL","NCT03221751|Prazosin and Cerebrospinal Fluid (CSF) Biomarkers in Mild Traumatic Brain Injury (mTBI)|TERMINATED|PHASE4|INTERVENTIONAL","NCT03817931|Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder|COMPLETED|PHASE4|INTERVENTIONAL","NCT04117178|Monitoring Anti-Dementia Drugs by Serum Levels|COMPLETED|PHASE4|INTERVENTIONAL","NCT04262206|Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults|RECRUITING|PHASE4|INTERVENTIONAL","NCT04294654|Vortioxetine in Patients With Depression and Early Dementia|COMPLETED|PHASE4|INTERVENTIONAL","NCT05514106|MIBG in Aging and Neurologic Disorders|ENROLLING_BY_INVITATION|PHASE4|INTERVENTIONAL","NCT05531591|RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)|COMPLETED|PHASE4|INTERVENTIONAL","NCT05855863|Clinical Study of GKT in Diabetes Related Dementia|NOT_YET_RECRUITING|PHASE4|INTERVENTIONAL","NCT06093126|Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial|RECRUITING|PHASE4|INTERVENTIONAL","NCT06662526|Lithium for Prevention of Cognitive Declining in Mood Illnesses|NOT_YET_RECRUITING|PHASE4|INTERVENTIONAL","NCT00009204|Serotonergic Pharmacotherapy for Agitation of Dementia|COMPLETED|PHASE3|INTERVENTIONAL","NCT00010803|Ginkgo Biloba Prevention Trial in Older Individuals|COMPLETED|PHASE3|INTERVENTIONAL","NCT00010920|Preventing Cognitive Decline With Alternative Therapies|COMPLETED|PHASE3|INTERVENTIONAL","NCT00034762|Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease|COMPLETED|PHASE3|INTERVENTIONAL","NCT00052104|Telephone-Based Support for Caregivers of Patients With Dementia|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00065689|High Intensity Light Therapy in Alzheimer's Disease|COMPLETED|PHASE3|INTERVENTIONAL","NCT00079651|Montessori-Based Activities for Elderly Persons With Dementia|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00095719|Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia|COMPLETED|PHASE3|INTERVENTIONAL","NCT00096473|Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease|COMPLETED|PHASE3|INTERVENTIONAL","NCT00105547|Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's|COMPLETED|PHASE3|INTERVENTIONAL","NCT00114530|Scleroderma: Cyclophosphamide or Transplantation|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00216502|A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease|COMPLETED|PHASE3|INTERVENTIONAL","NCT00216593|Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study|COMPLETED|PHASE3|INTERVENTIONAL","NCT00236431|A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment|COMPLETED|PHASE3|INTERVENTIONAL","NCT00236574|A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment|COMPLETED|PHASE3|INTERVENTIONAL","NCT00249145|A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia|COMPLETED|PHASE3|INTERVENTIONAL","NCT00249158|A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia|COMPLETED|PHASE3|INTERVENTIONAL","NCT00253123|A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia|COMPLETED|PHASE3|INTERVENTIONAL","NCT00253188|A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease|COMPLETED|PHASE3|INTERVENTIONAL","NCT00253201|A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease|COMPLETED|PHASE3|INTERVENTIONAL","NCT00253214|Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation|COMPLETED|PHASE3|INTERVENTIONAL","NCT00253227|A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease|COMPLETED|PHASE3|INTERVENTIONAL","NCT00255866|Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT00287742|A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease|TERMINATED|PHASE3|INTERVENTIONAL","NCT00315900|Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia|TERMINATED|PHASE3|INTERVENTIONAL","NCT00322036|Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's|TERMINATED|PHASE3|INTERVENTIONAL","NCT00338117|Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease|COMPLETED|PHASE3|INTERVENTIONAL","NCT00448318|Evaluating the Effects of Music Interventions on Hospitalised People With Dementia|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT00503516|Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia Patients|TERMINATED|PHASE2/PHASE3|INTERVENTIONAL","NCT00622128|Preventing Aggressive Behavior in Demented Patients|COMPLETED|PHASE3|INTERVENTIONAL","NCT00866099|Dementia Early Recognition and Response in Primary Care|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT00908492|Supporting Caregivers of Persons With Dementia: A Pilot Study|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT01021696|Pain in Patients With Dementia and Behavioural Disturbances|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT01194128|Facilitating Caregiver Adaptation to Patient Institutionalization|COMPLETED|PHASE3|INTERVENTIONAL","NCT01283750|Maximizing Independence at Home (MIND at Home)|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT01325714|Preventing Aggression in Veterans With Dementia|COMPLETED|PHASE3|INTERVENTIONAL","NCT01327859|Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia|COMPLETED|PHASE3|INTERVENTIONAL","NCT01760005|Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001|ACTIVE_NOT_RECRUITING|PHASE2/PHASE3|INTERVENTIONAL","NCT01886820|A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology|UNKNOWN|PHASE3|INTERVENTIONAL","NCT01969123|Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease|TERMINATED|PHASE3|INTERVENTIONAL","NCT01969136|Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease|TERMINATED|PHASE3|INTERVENTIONAL","NCT02004392|Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025|TERMINATED|PHASE3|INTERVENTIONAL","NCT02035982|Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease|COMPLETED|PHASE3|INTERVENTIONAL","NCT02248636|Cholinesterase Inhibitor Discontinuation|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT02350127|Preventing Loss of Independence Through Exercise (PLIE) in Persons With Dementia|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT02353949|Investigating the Clinical Consequences of Flutemetamol-PET-scanning|TERMINATED|PHASE3|INTERVENTIONAL","NCT02374567|Pharmacovigilance in Gerontopsychiatric Patients|TERMINATED|PHASE3|INTERVENTIONAL","NCT02813434|Cerebral Amyloid Imaging Using Florbetapir (AV-45)|UNKNOWN|PHASE3|INTERVENTIONAL","NCT03031184|Study of Mirtazapine for Agitation in Dementia|COMPLETED|PHASE3|INTERVENTIONAL","NCT03108846|Escitalopram for Agitation in Alzheimer's Disease|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT03682185|The Healthy Patterns Sleep Study|COMPLETED|PHASE3|INTERVENTIONAL","NCT03721705|Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type|COMPLETED|PHASE3|INTERVENTIONAL","NCT04623242|Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT05041582|SSRIs and TDCS Enhance Post-stroke Motor Recovery|UNKNOWN|PHASE3|INTERVENTIONAL","NCT05269394|Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)|ACTIVE_NOT_RECRUITING|PHASE2/PHASE3|INTERVENTIONAL","NCT05271552|Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)|COMPLETED|PHASE3|INTERVENTIONAL","NCT05428475|Implementation and Evaluation of Improved Access to Medical Imaging for Geriatric Patients of The Royal Ottawa Hospital|UNKNOWN|PHASE3|INTERVENTIONAL","NCT05470816|Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery: the TRIGS-D Trial|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT05508789|A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)|RECRUITING|PHASE3|INTERVENTIONAL","NCT05532657|ACHIEVE Brain Health Follow-Up Study|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL"]}]}